DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,918,490 | +4.2% | 15,794 | +0.8% | 3.52% | +9.1% |
| Q2 2023 | $3,761,520 | -3.3% | 15,673 | +1.6% | 3.22% | -8.8% |
| Q1 2023 | $3,889,734 | -3.9% | 15,433 | +1.2% | 3.54% | -10.4% |
| Q4 2022 | $4,048,717 | +4.9% | 15,254 | +2.0% | 3.95% | -3.9% |
| Q3 2022 | $3,861,000 | +2.7% | 14,948 | +0.8% | 4.11% | +8.9% |
| Q2 2022 | $3,759,000 | -25.5% | 14,828 | -13.8% | 3.78% | +2.5% |
| Q1 2022 | $5,044,000 | -11.2% | 17,196 | -0.4% | 3.68% | -4.0% |
| Q4 2021 | $5,683,000 | +8.0% | 17,273 | -0.0% | 3.84% | -7.0% |
| Q3 2021 | $5,260,000 | +1.2% | 17,281 | -10.8% | 4.13% | -5.9% |
| Q2 2021 | $5,198,000 | +13.3% | 19,369 | -4.9% | 4.38% | +8.1% |
| Q1 2021 | $4,586,000 | -0.9% | 20,375 | -2.2% | 4.05% | -4.7% |
| Q4 2020 | $4,629,000 | -0.1% | 20,839 | -3.2% | 4.25% | -9.6% |
| Q3 2020 | $4,634,000 | +15.6% | 21,521 | -5.1% | 4.70% | +5.0% |
| Q2 2020 | $4,010,000 | +24.2% | 22,680 | -2.8% | 4.48% | +3.2% |
| Q1 2020 | $3,228,000 | -12.6% | 23,327 | -3.1% | 4.34% | +6.2% |
| Q4 2019 | $3,694,000 | +5.9% | 24,072 | -0.3% | 4.09% | -3.1% |
| Q3 2019 | $3,487,000 | -6.8% | 24,141 | -7.8% | 4.22% | -1.7% |
| Q2 2019 | $3,741,000 | +1.1% | 26,176 | -6.6% | 4.29% | -1.6% |
| Q1 2019 | $3,700,000 | +27.6% | 28,037 | -0.3% | 4.36% | +8.3% |
| Q4 2018 | $2,899,000 | -8.5% | 28,115 | -3.5% | 4.03% | +13.5% |
| Q3 2018 | $3,167,000 | +10.5% | 29,143 | +0.4% | 3.55% | +1.3% |
| Q2 2018 | $2,865,000 | +1.1% | 29,032 | +0.3% | 3.50% | +0.2% |
| Q1 2018 | $2,834,000 | +7.9% | 28,936 | +2.2% | 3.50% | +10.3% |
| Q4 2017 | $2,626,000 | +27.5% | 28,301 | +17.9% | 3.17% | +9.3% |
| Q3 2017 | $2,059,000 | +12.3% | 23,996 | +10.5% | 2.90% | +10.3% |
| Q2 2017 | $1,833,000 | +10.2% | 21,721 | +11.8% | 2.63% | +3.3% |
| Q1 2017 | $1,663,000 | +29.0% | 19,437 | +17.4% | 2.55% | +12.8% |
| Q4 2016 | $1,289,000 | +32.3% | 16,560 | +33.3% | 2.26% | +32.4% |
| Q3 2016 | $974,000 | -12.0% | 12,425 | +13.4% | 1.71% | -13.4% |
| Q2 2016 | $1,107,000 | +60.2% | 10,958 | +50.4% | 1.97% | +62.6% |
| Q1 2016 | $691,000 | +81.4% | 7,285 | +77.7% | 1.21% | +65.3% |
| Q4 2015 | $381,000 | – | 4,100 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |